Clinical Trial Update: Ivacaftor for Acquired CFTR Dysfunction in Chronic Rhinosinusitis (EDSPD Protocol)

View source ↗

Summary

Clinical trial protocol evaluating ivacaftor for acquired CFTR dysfunction in chronic rhinosinusitis; the study is currently active but not recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Rhinosinusitis

Drugs mentioned

• Ivacaftor (ivacaftor)

Snippet

Sponsor: University of Alabama at Birmingham | Conditions: CRS | Status: ACTIVE_NOT_RECRUITING